Product Details
Highly Pushable Coaxial Shaft Design
The available low profile 3.8 F coaxial catheter shaft
design facilitates access to distal lesions
and allows reduction of access site complications¹ through the ability to use a 4F access sheath.
Tip
Smooth tapered tip entry profile promoting enhanced lesion crossing.
Predictable Balloon Expansion (Controlled Compliance)
The innovative balloon design and semi-crystalline polymer (SCP) material enable a predictable balloon compliance rate. This controlled compliance is designed to minimize the risk of dissection due to balloon over-dilatation.
Patchwork Coating for Enhanced Crossability
The penta-folded balloon is coated in a folded state, exposing uncoated balloon sections when inflated. This is intended to facilitate crossing while minimizing slippage during inflation.
Technical Data
Passeo-18 Balloon Catheter | |
---|---|
Catheter type |
OTW |
Recommended guide wire |
0.018" |
Tip |
Short, tapered |
Balloon material |
SCP (semi-crystalline polymer), controlled compliance (4 - 8 %) |
Balloon folding |
5-fold |
Balloon coating |
Hydrophobic patchwork coating |
Balloon markers |
2 swaged markers (zero profile) |
Sizes |
ø 2.0 - 7.0 mm; L: 20 - 200 mm |
Shaft |
3.8 F, 3.9 F (ø 6.0/7.0 mm x 170 - 200 mm); coaxial design |
Usable length |
90, 130 and 150 cm |
Compliance Chart
Balloon Diameter x Length (mm) | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nominal Pressure | atm3 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||
(NP) | ø (mm) | 2.0 | 2.0 | 2.5 | 2.5 | 3.0 | 3.0 | 3.5 | 3.5 | 4.0 | 4.0 | 5.0 | 5.0 | 5.0 | 6.0 | 7.0 | |||
Rated Burst Pressure | atm3 | 15 | 14 | 15 | 14 | 15 | 14 | 15 | 14 | 15 | 13 | 15 | 12 | 13 | 12 | 12 | |||
(RBP) | ø (mm) | 2.1 | 2.1 | 2.6 | 2.6 | 3.2 | 3.2 | 3.7 | 3.7 | 4.3 | 4.2 | 5.3 | 5.2 | 5.2 | 6.2 | 7.3 |
Order Information
Contact
1 Bosiers M, Deloose K, Callaert J, et al. 4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial. J Endovasc Ther. 2013; 20: 746-756.
2 8 weeks pre-order only
3 1 atm = 1.013 bar